Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
text
Tags
artificial intelligence
biotech
startups
arch venture partners
ayasdi
azacitidine
beta-thalassemia
bill martin
bio
biotechnology
boston
boston blog main
boston top stories
butterfly network
dacogen
deals
decitabine
deep learning
dna
drug development
drug discovery
enlitic
epigenetics
epizyme
executive
farydak
flagship pioneering
fulcrum therapeutics
funding
google
gv
health
ibm
insulated genomic domains
johnson & johnson
julie sunderland
kaleido biosciences
life sciences
lumiata
machine learning
What
approach
3
×
drugs
3
×
field
learning
new
therapeutics
aims
based
betting
big
biological
biotech
blackthorn
called
challenges
company
covering
create
data
debuts
deep
developing
discovery
disorders
drug
effective
epigenetic
epigenetics
essentially
finding
flagship’s
good
google
gv
health
highlighting
importantly
key
machine
medicine
Language
unset
Current search:
approach
×
drugs
×
@xconomy.com
5 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@techcrunch.com
5 years ago
Neurobehavioral health company Blackthorn pulls in $76 million from GV to treat mental disorders
@gigaom.com
9 years ago
Google, Stanford say big data is key to deep learning for drug discovery